Eidelman Virant Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $380K | Hold |
46,718
| – | – | 0.28% | 91 |
|
2022
Q2 | $329K | Hold |
46,718
| – | – | 0.24% | 102 |
|
2022
Q1 | $438K | Hold |
46,718
| – | – | 0.24% | 96 |
|
2021
Q4 | $374K | Buy |
46,718
+26,300
| +129% | +$211K | 0.14% | 120 |
|
2021
Q3 | $201K | Sell |
20,418
-40,000
| -66% | -$394K | 0.08% | 166 |
|
2021
Q2 | $600K | Hold |
60,418
| – | – | 0.23% | 87 |
|
2021
Q1 | $694K | Buy |
+60,418
| New | +$694K | 0.28% | 82 |
|